Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 80 years old?
Source: NCT06025331, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Lovisenberg Diakonale Hospital
- Trial code
- NCT06025331
- Record updated
- 7 November 2023
- Original description
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.Read full original descriptionShow less
From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (Study 1: Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?).
The goal of this clinical trial is to compare two different types of reverse shoulder replacements. Researchers will compare a conventional reverse shoulder replacement with a lateralized reverse shoulder replacement to see if there is a difference in how well the patients function after two years.
Inclusion: Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis; Able to read or write Norwegian.
Exclusion: Revision surgery; Dementia; Suspected chronic infection; Severe osteoporosis; Osteonecrosis of the humeral head; Poor deltoid function; ASA IV; Acute fracture.